MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes

Area of Science:

• Cellular physiology
• Molecular biology
• Renal medicine

Background:

• Calcium/calcineurin signaling is vital for cellular function.
• Dysregulation of this pathway is implicated in diseases like podocytopathy.
• Understanding regulatory mechanisms is crucial for disease intervention.

Purpose of the Study:

• To investigate the role of microRNA-30 family (miR-30s) in regulating calcium/calcineurin signaling.
• To identify specific targets of miR-30s within this pathway.
• To explore the implications of miR-30s dysregulation in podocytopathy and related conditions.

Main Methods:

• Analysis of gene and protein expression in podocytes from healthy individuals, rats treated with puromycin aminonucleoside (PAN), and focal segmental glomerulosclerosis (FSGS) patients.
• Utilizing miR-30 sponge technology in cultured podocytes and in vivo mouse models.
• Assessing calcium influx, intracellular Ca2+ concentration, calcineurin activity, and downstream signaling events.
• Investigating the effects of calcineurin inhibition (FK506).

Main Results:

• miR-30s directly target critical calcium/calcineurin signaling components (TRPC6, PPP3CA, PPP3CB, PPP3R1, NFATC3).
• miR-30s are downregulated in podocytes during FSGS and PAN-induced nephropathy.
• Reduced miR-30s levels enhance calcium/calcineurin signaling, leading to podocyte injury markers (NFATC3 activation, synaptopodin degradation, actin loss).
• In vivo miR-30 sponge expression causes podocyte effacement and proteinuria, preventable by FK506.
• miR-30s also regulate this pathway in cardiomyocytes.

Conclusions:

• miR-30s are essential regulators of the calcium/calcineurin signaling pathway.
• Dysregulation of miR-30s contributes to the pathogenesis of podocytopathy and potentially other conditions.
• Targeting miR-30s may offer a therapeutic strategy for diseases involving calcium/calcineurin signaling abnormalities.